Morning blood pressure surge and its relation to insulin resistance in patients of reproductive age with polycystic ovary syndrome

Table 1 Basal characteristics of the groups

Variable\Group	Control Group	PCOS Group	p
Age, year	27 (20–33)	27.5 (22–33)	0.383
BMI, kg/m²	22 (19–28)	24.1 (19.6–29.5)	0.001*
Insulin, pg/ml	8 (3.38–45.56)	18.9 (4.85–48.6)	< 0.001*
Office systolic BP, mmHg	110.5 ± 9.5	120.5 ± 7.2	< 0.001*
Office diastolic BP, mmHg	72.6 ± 6.2	73.4 ± 5.4	0.478
HOMA-IR	1.75 (0.68–9.54)	4.27 (1.04–9.36)	< 0.001*
Creatinine, mg/dl	0.7 (0.6–0.9)	0.8 (0.6–0.9)	0.135
Total Cholesterol, mg/dl	169 ± 24	175 ± 23	0.224
Triglyceride, mg/dl	123 (81–210)	156 (68–247)	0.044*
HDL-C, mg/dl	52 (34–65)	45.5 (33–66)	0.004*
LDL-C, mg/dl	90 ± 30	100 ± 20	0.044*
Insulin resistance, n (%)	22 (30)	29 (76)	< 0.001*

BP Blood pressure, BMI Body mass index, HOMA-IR The homeostasis model assessment of insulin resistance, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, PCOS Polycystic ovary syndrome. Age, insulin, HOMA-IR, creatinine, and triglyceride were presented as median (maximum-minimum), total cholesterol, LDL-C, were presented as mean standard ± deviation. * indicated a significant difference between controls and patients with polycystic ovary syndrome

ISSN: 1477-7827